Great News for Anemia Sufferers, AMAG

All too often, big business wins out over the interests of the little guy or vice versa. However, the FDA approval of AMAG Pharmaceutical Inc’s Feraheme, an anemia medicine taking by injection, has proven to be beneficial to both parties. Shares of AMAG, a relatively small business, are up 5 percent, while anemia sufferers now have a new, more convenient drug available.
 
Feraheme has specifically been approved for adults as part of an iron replacement treatment for those afflicted with kidney disease. According to the company, chronic kidney disease suffers at every level of severity will have what is effectively a …read more